Pharmaceutical products — whether originator or follow-on — are required to meet the same quality, safety and efficacy standards set by regulatory authorities before they can be marketed in India. Understanding this equivalence builds confidence in prescribing and dispensing decisions.
For many patients, access to affordable, quality medicines represents the difference between consistent treatment and discontinuing therapy due to cost. The regulatory framework governing pharmaceutical approvals ensures that affordability does not come at the expense of efficacy or safety.
Regulatory authorities require pharmaceutical products to demonstrate bioequivalence to a reference product, meaning the medicine performs comparably in the body. This is the scientific foundation underpinning confidence in every quality-certified pharmaceutical product.
Published by AcambisIndia Pharmaceuticals · This article is for general informational purposes and does not constitute medical advice. Please consult a qualified healthcare professional for guidance specific to your condition.
← Back to Blog